Emeline Keller

850 total citations
16 papers, 715 citations indexed

About

Emeline Keller is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Emeline Keller has authored 16 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Emeline Keller's work include Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Emeline Keller is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Emeline Keller collaborates with scholars based in France, Cuba and United Kingdom. Emeline Keller's co-authors include Tangui Maurice, Vanessa Villard, A Vamvakidès, Julie Espallergues, Laurent Givalois, Nathalie Chevallier, Gaëlle Naert, Charleine Zussy, Anthony Brureau and Stéphane Marchal and has published in prestigious journals such as PLoS ONE, Scientific Reports and American Journal Of Pathology.

In The Last Decade

Emeline Keller

16 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emeline Keller France 10 326 317 194 189 110 16 715
Sylvie Burnouf France 15 213 0.7× 399 1.3× 263 1.4× 120 0.6× 130 1.2× 19 728
Nan Lin China 14 303 0.9× 262 0.8× 112 0.6× 82 0.4× 193 1.8× 30 722
Carlos F. Burgos Chile 14 303 0.9× 192 0.6× 220 1.1× 82 0.4× 52 0.5× 41 590
Larry D. Altstiel United States 13 336 1.0× 427 1.3× 125 0.6× 137 0.7× 297 2.7× 19 879
Jinwang Ye China 13 275 0.8× 274 0.9× 139 0.7× 103 0.5× 140 1.3× 20 606
Jasna Jerecı̀ć United States 11 406 1.2× 673 2.1× 233 1.2× 242 1.3× 162 1.5× 18 985
Antonio Dominguez‐Meijide Spain 21 398 1.2× 297 0.9× 417 2.1× 88 0.5× 286 2.6× 27 1.2k
Carlos Morgan Chile 13 235 0.7× 351 1.1× 94 0.5× 166 0.9× 47 0.4× 26 716
Sharon Little United States 6 368 1.1× 649 2.0× 163 0.8× 173 0.9× 122 1.1× 7 847
Dolores Del Prete United States 12 392 1.2× 484 1.5× 290 1.5× 144 0.8× 107 1.0× 18 858

Countries citing papers authored by Emeline Keller

Since Specialization
Citations

This map shows the geographic impact of Emeline Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emeline Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emeline Keller more than expected).

Fields of papers citing papers by Emeline Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emeline Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emeline Keller. The network helps show where Emeline Keller may publish in the future.

Co-authorship network of co-authors of Emeline Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Emeline Keller. A scholar is included among the top collaborators of Emeline Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emeline Keller. Emeline Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Keller, Emeline, et al.. (2024). Psyllium husk powder increases defecation frequency and faecal score, bulk and moisture in healthy cats. Journal of Feline Medicine and Surgery. 26(4). 1098612X241234151–1098612X241234151. 4 indexed citations
2.
Keller, Emeline, et al.. (2020). Use of reduced-energy content maintenance diets for modest weight reduction in overweight cats and dogs. Research in Veterinary Science. 131. 194–205. 6 indexed citations
3.
Naert, Gaëlle, Valentine Marie Ferré, Emeline Keller, et al.. (2017). In vivo and ex vivo analyses of amyloid toxicity in the Tc1 mouse model of Down syndrome. Journal of Psychopharmacology. 32(2). 174–190. 4 indexed citations
4.
Reggiani, Angelo, Elena Simoni, Roberta Caporaso, et al.. (2016). In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer’s Disease. Scientific Reports. 6(1). 33172–33172. 33 indexed citations
5.
Naert, Gaëlle, Valentine Marie Ferré, Johann Meunier, et al.. (2015). Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25–35 peptide administration in mice. European Neuropsychopharmacology. 25(11). 2170–2182. 48 indexed citations
7.
Zussy, Charleine, Anthony Brureau, Emeline Keller, et al.. (2013). Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats. PLoS ONE. 8(1). e53117–e53117. 101 indexed citations
9.
Zussy, Charleine, Anthony Brureau, Stéphane Marchal, et al.. (2011). Time-Course and Regional Analyses of the Physiopathological Changes Induced after Cerebral Injection of an Amyloid β Fragment in Rats. American Journal Of Pathology. 179(1). 315–334. 111 indexed citations
10.
Chevallier, Nathalie, Emeline Keller, & Tangui Maurice. (2011). Behavioural phenotyping of knockout mice for the sigma-1 (σ1) chaperone protein revealed gender-related anxiety, depressive-like and memory alterations. Journal of Psychopharmacology. 25(7). 960–975. 52 indexed citations
11.
Villard, Vanessa, Julie Espallergues, Emeline Keller, A Vamvakidès, & Tangui Maurice. (2010). Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma11) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative. Journal of Psychopharmacology. 25(8). 1101–1117. 117 indexed citations
12.
Villard, Vanessa, Julie Espallergues, Emeline Keller, et al.. (2008). Antiamnesic and Neuroprotective Effects of the Aminotetrahydrofuran Derivative ANAVEX1-41 Against Amyloid β25–35-Induced Toxicity in Mice. Neuropsychopharmacology. 34(6). 1552–1566. 95 indexed citations
13.
Rassoul, F, et al.. (2001). Long-term administration of the HMG-CoA reductase inhibitor lovastatin in two patients with cholesteryl ester storage disease. International Journal of Clinical Pharmacology and Therapeutics. 39(5). 199–204. 16 indexed citations
14.
Mestre‐Francés, Nadine, Emeline Keller, Alphonse Calenda, et al.. (2000). Immunohistochemical Analysis of Cerebral Cortical and Vascular Lesions in the Primate Microcebus murinus Reveal Distinct Amyloid β1–42 and β1–40 Immunoreactivity Profiles. Neurobiology of Disease. 7(1). 1–8. 48 indexed citations
15.
Fisher, Abraham & Emeline Keller. (2000). Cognitive and behavioral improvements in aged primate microcebus murinus following one year treatment with the M1 muscarinic agonist, AF150(S). Neurobiology of Aging. 21. 19–19. 3 indexed citations
16.
Keller, Emeline, et al.. (1977). [Cholesterol-ester storage disease of the liver in childhood].. PubMed. 37(5-6). 231–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026